Elevance Health, Inc.

ELV

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001748691-26-000002
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Kaye Mark (CFO)

Summary

Type

Sell

Net shares

+15,955

% of shares

99.21%

Amount (USD)

$179,955

Insider confidence score

95.0 out of 100

Positive

  • Massive buy (≥10% of shares)
  • Significant buy amount ($50K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Tax_withhold

Date

2026-03-02

Code

F

Net shares

-271.0

Price per Share

$294.07

Amount (USD)

$79,692.97

Acquired/Disposed

Disposed

Shares Owned Before

16,082.0

Shares Owned After

15,811.0

Transaction 2

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+6,377.0

Acquired/Disposed

Acquired

Shares Owned Before

15,811.0

Shares Owned After

22,188.0

Transaction 3

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+10,202.0

Acquired/Disposed

Acquired

Shares Owned Before

22,188.0

Shares Owned After

32,390.0

Transaction 4

Security

Common Stock

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-353.0

Price per Share

$284.03

Amount (USD)

$100,262.59

Acquired/Disposed

Disposed

Shares Owned Before

32,390.0

Shares Owned After

32,037.0

Derivative Transactions

Transaction 1

Security

Employee Stock Option (Right to Buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+25,188.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

25,188.0

Filing's footnotes

1. PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

2. Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029.

3. Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028.

4. The option represents a right to purchase a total of 25,188 shares, and is exercisable in three annual installments, each installment of 8,396 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.